医学临床研究
  2025年7月18日 星期五           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2023, Vol. 40 Issue (10): 1508-1511    DOI: 10.3969/j.issn.1671-7171.2023.10.019
  论著 本期目录 | 过刊浏览 | 高级检索 |
IFN-γ、IL-4在急性创伤性脊髓损伤合并感染患者血清中的表达水平及其临床意义
李旺1, 李佳平2*
1.西安市人民医院(西安市第四医院)急诊科,陕西 西安 710000;
2.富县人民医院骨科,陕西 延安 727500
Expression Levels of IFN-γ and IL-4 in Serum of Patients with Acute Traumatic Spinal Cord Injury Complicated with Infection and their Clinical Significance
LI Wang, LI Jiaping
Department of Emergency, Xi'an People's Hospital (The Fourth Hospital of Xi'an), Xi'an Shaanxi 710000
全文: PDF (1231 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨γ干扰素(IFN-γ)、白细胞介素-4(IL-4)在急性创伤性脊髓损伤合并感染患者血清中的表达水平及其临床意义。【方法】回顾性分析2017年2月至2022年2月在西安市人民医院(西安市第四医院)诊治的86例急性创伤性脊髓损伤患者,根据创伤后是否合并感染分为感染组(n=26)及非感染组(n=60)。比较两组患者基本资料及IFN-γ、IL-4水平;采用多因素Logistic回归分析急性创伤性脊髓损伤患者创伤后合并感染的影响因素;采用受试者工作特征(ROC)曲线分析IL-4、IFN-γ对急性创伤性脊髓损伤患者创伤后合并感染的预测价值。【结果】感染组患者年龄≥60岁占比、美国脊柱损伤协会(ASIA)分级为完全损伤占比、受伤到入院时间≥48 h占比、未使用预防性抗生素占比、IL-4水平均高于非感染组,IFN-γ水平低于非感染组(P<0.05); ROC曲线分析结果显示:IL-4、IFN-γ可用于急性创伤性脊髓损伤患者创伤后合并感染的预测,曲线下面积分别为0.875、0.906; Logisitic回归分析结果显示:年龄≥60岁、ASIA分级为完全损伤、受伤到入院时间≥48 h、未使用预防性抗生素、IFN-γ≤14.084 pg/mL、IL-4≥79.711 pg/mL均是导致急性创伤性脊髓损伤患者创伤后合并感染的危险因素(P<0.05)。【结论】IL-4、IFN-γ水平与急性创伤性脊髓损伤患者创伤后发生感染显著相关,动态监测IL-4、IFN-γ水平变化,有助于判断创伤后的感染情况。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
李旺
李佳平
关键词 脊髓损伤/并发症感染/并发症干扰素γ/血液白细胞介素4/血液    
Abstract:【Objective】To investigate the expression levels and clinical significance of interferon-γ (IFN-γ) and interleukin-4 (IL-4) in the serum of patients with acute traumatic spinal cord injury complicated with infection. 【Methods】A retrospective analysis was conducted on 86 patients with acute traumatic spinal cord injury treated in our hospital from February 2017 to February 2022. The patients were divided into infection group (n=26) and non-infection group (n=60). The basic information and levels of IFN-γ and IL-4 were compared between the two groups. Multivariate Logistic regression was used to analyze the factors affecting post-injury infection in patients with acute traumatic spinal cord injury. The predictive value of IL-4 and IFN-γ for post-injury infection was analyzed using the receiver operating characteristic (ROC) curve. 【Results】The proportion of patients aged ≥60 years, ASIA (American Spinal Injury Association) score indicating complete injury, time from injury to admission ≥48 hours, and not using prophylactic antibiotics was higher in the infection group. IL-4 levels were higher and IFN-γ levels were lower in the infection group compared to the non-infection group (P<0.05). ROC curve analysis confirmed that IL-4 and IFN-γ can be used to predict post-injury infection in patients with acute traumatic spinal cord injury, with area under the curve (AUC) values of 0.875 and 0.906. Logistic regression analysis showed that age ≥60 years, ASIA score indicating complete injury, time from injury to admission ≥48 hours, not using prophylactic antibiotics, IFN-γ ≤14.084 pg/mL, and IL-4 ≥79.711 pg/mL were risk factors for post-injury infection in patients with acute traumatic spinal cord injury (P<0.05). 【Conclusion】The levels of IL-4 and IFN-γ are significantly correlated with the occurrence of post-injury infection in patients with acute traumatic spinal cord injury. Dynamic monitoring of IL-4 and IFN-γ levels can help assess the risk of post-injury infection complications.
Key wordsSpinal Cord Injuries/CO    Infections/CO    Interferon-gamma/BL    Interleukin-4/BL
收稿日期: 2022-12-28     
中图分类号:  R651.2  
通讯作者: *E-mail:276324565@qq.com   
引用本文:   
李旺, 李佳平. IFN-γ、IL-4在急性创伤性脊髓损伤合并感染患者血清中的表达水平及其临床意义[J]. 医学临床研究, 2023, 40(10): 1508-1511.
LI Wang, LI Jiaping. Expression Levels of IFN-γ and IL-4 in Serum of Patients with Acute Traumatic Spinal Cord Injury Complicated with Infection and their Clinical Significance. JOURNAL OF CLINICAL RESEARCH, 2023, 40(10): 1508-1511.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2023.10.019     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2023/V40/I10/1508
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn